By inhibiting lactate metabolism, particularly through LDHA inhibitors, the lactylation of NBS1 at K388 can be effectively reduced, overcoming chemotherapy resistance, and markedly improving the prognosis of patients with cancer [66]. Here, LDHA is linked to cancer.